Literature DB >> 11122078

Problems in laboratory monitoring of heparin dosage.

S Kitchen1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11122078     DOI: 10.1046/j.1365-2141.2000.02308.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  6 in total

Review 1.  Pathology tests: is the time for demand management ripe at last?

Authors:  G Gopal Rao; M Crook; M L Tillyer
Journal:  J Clin Pathol       Date:  2003-04       Impact factor: 3.411

2.  Monitoring of heparin and its low-molecular-weight analogs by silicon field effect.

Authors:  Nebojsa M Milovic; Jonathan R Behr; Michel Godin; Chih-Sheng Johnson Hou; Kristofor R Payer; Aarthi Chandrasekaran; Peter R Russo; Ram Sasisekharan; Scott R Manalis
Journal:  Proc Natl Acad Sci U S A       Date:  2006-08-28       Impact factor: 11.205

Review 3.  Measuring anti-factor xa activity to monitor low-molecular-weight heparin in obesity: a critical review.

Authors:  Gregory Egan; Mary H H Ensom
Journal:  Can J Hosp Pharm       Date:  2015 Jan-Feb

4.  Design and Implementation of an Anti-Factor Xa Heparin Monitoring Protocol.

Authors:  Tanya Williams-Norwood; Megan Caswell; Barbara Milner; Joseph C Vescera; Kelly Prymicz; Amy G Ciszak; Carol Ingle; Christopher Lacey; Evi X Stavrou
Journal:  AACN Adv Crit Care       Date:  2020-06-15

5.  Inhibition of intrinsic thrombin generation.

Authors:  Thomas W Stief
Journal:  Drug Target Insights       Date:  2006-10-23

6.  Accuracy, reproducibility and costs of different laboratory assays for the monitoring of unfractionated heparin in clinical practice: a prospective evaluation study and survey among Swiss institutions.

Authors:  Susanne Bürki; Béatrice Brand; Robert Escher; Walter A Wuillemin; Michael Nagler
Journal:  BMJ Open       Date:  2018-06-09       Impact factor: 2.692

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.